UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform
UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform.
UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform.
Healthleap, a clinical AI platform that works within the EHR to screen hospitalized patients for conditions that might otherwise go undiagnosed, is supporting hospitals in finding at-risk patients sooner.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Data, behavioral insights, and experimentation can be used to understand how stress, motivation, and trust shape company culture. Positively changing company culture leads to direct improvements in patient health outcomes, clinician wellbeing, and company performance.
In this episode of the MedCity Pivot Podcast, CEO Priya Abani talks about the evolution of AliveCor, one of the earliest digital health companies.
When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 Physician Drug Cost Survey by RazorMetrics examined how prescription cost pressures affect physicians’ practices.
Healthcare has a habit of embracing patient empowerment right up until patients become powerful.
Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.
The American College of Physicians is urging policymakers to expand access to obesity treatment and healthy foods while investing in prevention and research.
The policy conversation needs to shift from just deprescribing alone to building the clinical infrastructure that delivers consistent, high-quality behavioral health care.
The opportunity ahead is to treat physician well-being as a core strategic priority, measured with the same rigor and acted upon with the same urgency as any other critical performance domain.
This is not an argument against capital in independent medicine. Practices need infrastructure, and physicians have legitimate reasons to seek liquidity. It is an argument that the exit stage carries a risk this market has not yet priced.
When education is incomplete, patients don’t just feel uninformed; they feel dismissed.
AI documentation tools are genuinely useful. But they are treating a symptom, not the disease. The disease is that physicians have lost control over how they work.
The real question is whether we're being honest with ourselves about what medical education was designed to produce, and whether our current system is still doing that job.
As breast cancer treatment continues to improve, our focus must expand beyond survival to encompass the quality of life during and after treatment.
As demand for long-term care rises, workforce stability is no longer just an operational concern. It is increasingly a direct measure of care quality itself. Organizations that fail to recognize this shift risk undermining both outcomes and access.